Biognosys in Publications 2024

We are proud to highlight the diverse range of applications supported by our proteomics software in[...]

IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights

[...]

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress

Biognosys’[...]

Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems

Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research

[...]

Spectronaut^® 19: Unlock Your Data’s True Story

Spectronaut® 19 goes above and beyond to bring you more biologically relevant targets than before, and solutions that make large-scale proteomics analysis a breeze. This new[...]

Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference

[...]

Biognosys Launches Groundbreaking P2 Plasma Enrichment Technology for Unbiased, Deep Plasma Proteomics at ASMS 2024

[...]

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics [...]

Biognosys Unveils Enhanced Plasma Proteomics Services for Deep and High-Throughput Biomarker Discovery

The new workflows leverage an innovative plasma enrichment method, delivering deep proteome coverage with exceptional data quality, reproducibility, and efficiency. The platform[...]

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

The new lab facility in Newton, Massachusetts ensures closer proximity to US customers and provides domestic access to select CRO services for discovery proteomics. Biognosys’[...]

Biognosys Introduces Higher-Throughput Discovery Proteomics Research Services Based on the Bruker timsTOF Platform

Biognosys, a leader in next-generation proteomics solutions for biomarker discovery and drug development, today announced a significant enhancement to its portfolio of discovery[...]

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics, expected to[...]